IMS Capital Management’s Eli Lilly LLY Stock Holding History

IMS Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$243K	Sell	319 -40	-11%	-$29.8K	0.11%	132
2025 Q2	$280K	Sell	359 -1,920	-84%	-$1.49M	0.13%	123
2025 Q1	$1.88M	Buy	2,279 +2,000	+717%	+$1.66M	0.95%	37
2024 Q4	$215K	Hold	279	–	–	0.1%	133
2024 Q3	$247K	Hold	279	–	–	0.11%	126
2024 Q2	$265K	Hold	279	–	–	0.12%	119
2024 Q1	$217K	Buy	+279	New	+$199K	0.1%	138
2020 Q2	–	Sell	-1,541	Closed	-$214K	–	128
2020 Q1	$214K	Buy	+1,541	New	+$212K	0.22%	100
2018 Q4	–	Sell	-120	Closed	-$13K	–	249
2018 Q3	$13K	Buy	+120	New	+$12K	0.01%	292

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

IMS Capital Management's LLY Position: Q3 2025 in Review

IMS Capital Management reduced its Eli Lilly (LLY) stake by 11% in Q3 2025, selling an estimated $29.8K and leaving 319 shares worth $243K. The position accounts for 0.11% of the portfolio, ranked #132.

IMS Capital Management first reported a position in LLY in Q3 2018 and has held it in 9 quarters since. The position peaked at $1.88M in Q1 2025. 3,898 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

IMS Capital Management held 319 shares of Eli Lilly worth $243K as of Q3 2025.
IMS Capital Management sold 40 Eli Lilly shares in Q3 2025, an estimated $29.8K.
Eli Lilly made up 0.11% of IMS Capital Management's portfolio in Q3 2025, its #132 holding.
IMS Capital Management first reported a position in Eli Lilly in Q3 2018 and has held it in 9 quarters since.
IMS Capital Management's Eli Lilly position peaked at $1.88M in Q1 2025.
3,898 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on IMS Capital Management's 13F filing for Q3 2025, filed 17 Nov 2025.